Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Tianjin Weikai In-licenses China Rights to 3D Cell Culture System from Zyoxel

publication date: Jul 10, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Tianjin Weikai obtained exclusive China rights to manufacture and distribute TissueFlex® from Zyoxel Limited of Oxford, UK. TissueFlex® is a microbioreactor for 3D perfused cell culture. Zyoxel will receive royalties for each system sold. Zyoxel and Weikai both focus on stem cell technologies. Weikai offers stem cell CRO services and products. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners